Maintaining the balance between compliance and efficiency is what will set a CRO apart in the highly competitive outsourcing landscape and inspire the sponsor’s confidence.
Drug sponsors value – and rely on – the work that CROs perform. CROs have a chance to up their data management game. How can they ensure data quality?
Learn the importance of enterprise control in getting CGTs to market – and the critical systems that enable this control in cell-based therapy manufacturing.
Now that we know what a microservice is and why it’s important, let’s explore deploying and managing cloud microservices in GxP environments.
What is a microservice? Let’s explore the term’s meaning, the benefits and how it can help boost your data security.
BioProcess International took place in Vienna this year, with talks centred around six main streams including cell line development and engineering, cell culture, recovery and purification, viral safety, cell and gene therapy as well as smaller sessions for manufacturing strategy and Industry 4.0 and vaccine manufacturing.
It’s been a busy year so far. And we’re only at the start of April! Find out what we’ve been up to in this blog.
While you may not find yourself Kitesurfing in Barbados, intuitive cell line selection unleashing powerful high throughput capabilities promises to be exhilarating.
For those of us who develop software that supports the biopharmaceutical/life science industry, the challenges and opportunities in digital transformation are painfully obvious and it can be easy to forget that not everyone sees it that way. Let’s try another way…
While 2021 was another challenging year in many respects, the life science industry still managed some notable achievements.